Nexafed Gains Rite Aid Sales, But Stumbles In Extraction-Proof PSE Tests
This article was originally published in The Tan Sheet
Executive Summary
As Nexafed distribution picks up momentum, Acura hits a setback in developing a 100% extraction-resistant formulation of its PSE decongestant. Rite Aid, the first national drug store chain to carry Nexafed, is selling only tamper-deterrent, single-ingredient PSE formulations in West Virginia and will consider making the change in other states.
You may also be interested in...
PSE Product Makes “Highly” Tamper-Resistant Claim With 100% Out Of Reach
Westport Pharmaceuticals says a claim of being “highly” resistant to PSE-extraction distinguishes Zephrex-D from the competition, but the distinction alone is not adding up to market-share gains in the nonprescription nasal decongestant space.
PSE Product Makes “Highly” Tamper-Resistant Claim With 100% Out Of Reach
Westport Pharmaceuticals says a claim of being “highly” resistant to PSE-extraction distinguishes Zephrex-D from the competition, but the distinction alone is not adding up to market-share gains in the nonprescription nasal decongestant space.
Tamper-Resistant Pseudoephedrine Sparks Pharmacies’ Interest
Ohio and West Virginia chain Fruth Pharmacy begins replacing the 30 mg PSE products available in its stores with Acura Pharmaceuticals’ Nexafed product. Meanwhile, DEA says Westport Pharmaceuticals should not make an extraction-proof claim for its Zephrex-D PSE product.